Neuland Laboratories Ltd Share Price Neuland Labs.

484.50

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

484.10

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 30-Oct-2019 - -
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2019. Results Release and Earnings Call Notice under Regulation 30 SEBI (Listing Obligations and Disclosure Requirements), 2015 (As Per BSE Announcement Dated on 07.11.2019) This is to inform you that the Board of Directors, at their meeting held on even date, has inter alia, approved the Unaudited Financial Results (standalone & consolidated) of the Company for the quarter and half-year ended September 30, 2019. Please find enclosed the financial results for the quarter and half-year ended September 30, 2019, along with a copy of the limited review reports (standalone & consolidated) by the Statutory auditors of the Company. The meeting of the Board of Directors of the Company commenced at 01:15 pm and concluded at 03:30 pm (As Per BSE Announcement Dated on 14/11/2019) Please find attached herewith copies of the newspaper publication of Un-audited financial results for the quarter and half year ended September 30, 2019, published in Financial Express and Andhra Prabha on November 15, 2019 for your reference. (As per BSE Announcement Dated on 15.11.2019)
Board Meeting - 16-Jul-2019 - -
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2019 ,inter alia, to consider and approve To consider and approve the in-audited financial results for the quarter ended June 30, 2019 Newspaper publication dated July 17, 2019 (As Per BSE Announcement Dated 17.07.2019) Outcome of Board Meeting (As Per BSE Announcement Dated On 13/08/2019)
Board Meeting - 03-Apr-2019 - -
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2019 ,inter alia, to consider and approve To consider and take on record the Audited financial results of the Company for the year ended March 31, 2019 Publication of Notice of Board Meeting (As Per BSE Announcement Dated On 04/04/2019) Company Update (As Per BSE Announcement Dated On 02/05/2019) Board approved Dividend for FY 2018-19 Audited Financial Results for quarter and Financial year ended March 31, 2019 Outcome of Board Meeting held on May 16, 2019 Disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015 (As Per BSE Announcement Dated on 16.05.2019)
Board Meeting - 16-Jan-2019 - -
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2019 ,inter alia, to consider and approve To consider and take on record the un-audited financial results of the Company for the quarter ended December 31, 2018 Disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015 (As Per BSE Announcement Dated 12.02.2019) Update (As Per BSE Announcement Dated 14.02.2019)